Eckhart Weidmann

7.8k citations
116 papers · 5.4k · 1 hit paper · h-index 39

Impact in

Papers in

Eckhart Weidmann

113 papers receiving 5.2k citations

Eckhart Weidmann's Hit Papers

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial 2013 · 1.0k citations
1.0k0+4+8Years since publication2505007501000

Peers

Eckhart Weidmann
Comparison fields: 5 of 112
  • Pathology and Forensic Medicine 2.1k
  • Genetics 1.2k
  • Oncology 1.7k
  • Hematology 703
  • Immunology 1.2k
Replace Livio Trentin with:
Livio Trentin Italy
Renato Zambello Italy
Elizabeth Hyjek United States
M Tulliez France
I T Magrath United States
TM Grogan United States
Martin Gramatzki Germany
Giuseppe Visani Italy
Vallì De Re Italy
V. Leblond France
Eckhart Weidmann relative to Livio Trentin Italy Livio Trentin's profile →
Citations per field
00.5×1.5×
Livio Trentin · 1×
Citations per year

Countries citing papers authored by Eckhart Weidmann

Since Specialization
Citations

This map shows the geographic impact of Eckhart Weidmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eckhart Weidmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eckhart Weidmann more than expected).

Fields of papers citing papers by Eckhart Weidmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eckhart Weidmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eckhart Weidmann. The network helps show where Eckhart Weidmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Eckhart Weidmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eckhart Weidmann Line = papers co-authored together Eckhart Weidmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
Hit paper breakdown →
20131013
2 1997298
3 1994277
4 2000178
5 2000172
6 1998135
7 2009116
8 2015115
9 2009104
10 1999104
11
The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells.
199499
12
The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro.
199797
13 199579
14 200278
15
Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
199275
16 201370
17 201169
18 199969
19 200265
20 201565

About Eckhart Weidmann

Eckhart Weidmann is a scholar working on Pathology and Forensic Medicine, Molecular Biology, Immunology, Oncology and Hematology, having authored 116 papers that have together received 5.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (39 papers), Immune Cell Function and Interaction (18 papers), Chronic Lymphocytic Leukemia Research (18 papers), Immunotherapy and Immune Responses (16 papers), Cell death mechanisms and regulation (14 papers), Acute Myeloid Leukemia Research (14 papers), Renal and related cancers (11 papers) and CAR-T cell therapy research (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.1k citations), Genetics (1.2k citations), Oncology (1.7k citations), Hematology (703 citations) and Immunology (1.2k citations). Eckhart Weidmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Lothar Bergmann, Dieter Hoelzer, Ulrich Maurer, Paris S. Mitrou, D. Hoelzer, Jürgen Brieger, Mathias Rummel, T. Karakas, Wolfram Brugger and Ulrich Kaiser. Their work appears in journals such as Blood, Annals of Oncology, Leukemia Research, International Journal of Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact